Adit EdTech Acquisition Price to Book Ratio 2021-2023 | ADEX
Historical price to book ratio values for Adit EdTech Acquisition (ADEX) over the last 10 years. The current price to book ratio for Adit EdTech Acquisition as of May 09, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Adit EdTech Acquisition Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2023-12-29 | 5.38 | 0.00 | |
2023-09-30 | 10.67 | $-2.30 | -4.64 |
2023-06-30 | 10.56 | $-2.21 | -4.79 |
2023-03-31 | 10.34 | $-2.02 | -5.12 |
2022-12-31 | 10.11 | $-1.80 | -5.61 |
2022-09-30 | 9.89 | $-1.99 | -4.97 |
2022-06-30 | 9.84 | $-1.95 | -5.04 |
2022-03-31 | 9.88 | $-2.31 | -4.27 |
2021-12-31 | 9.90 | $-2.49 | -3.98 |
2021-09-30 | 9.74 | $-1.32 | -7.36 |
2021-06-30 | 9.69 | $0.60 | 16.02 |
2021-03-31 | 9.63 | $0.61 | 15.90 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.048B | $0.020B |
Adit EdTech Acquisition Corp. entered into a definitive merger agreement with Griid Infrastructure LLC. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $123.960B | 15.55 |
Cencora (COR) | United States | $44.706B | 17.43 |
ICON (ICLR) | Ireland | $25.718B | 24.28 |
DiDi Global (DIDIY) | China | $23.622B | 0.00 |
Avantor (AVTR) | United States | $16.493B | 24.28 |
CochLear (CHEOY) | Australia | $14.172B | 0.00 |
Viatris (VTRS) | United States | $14.062B | 4.04 |
Revvity (RVTY) | United States | $12.689B | 22.26 |
Charles River Laboratories (CRL) | United States | $12.120B | 22.09 |
Medpace Holdings (MEDP) | United States | $12.009B | 39.51 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.810B | 0.00 |
Natera (NTRA) | United States | $11.552B | 0.00 |
Solventum (SOLV) | United States | $11.460B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.363B | 0.00 |
HealthEquity (HQY) | United States | $6.693B | 50.01 |
Organon (OGN) | United States | $5.239B | 4.97 |
Bausch + Lomb (BLCO) | Canada | $5.204B | 20.86 |
Doximity (DOCS) | United States | $4.455B | 33.17 |
PACS (PACS) | United States | $3.704B | 0.00 |
Surgery Partners (SGRY) | United States | $3.453B | 31.59 |
Sotera Health (SHC) | United States | $3.175B | 15.58 |
Progyny (PGNY) | United States | $3.091B | 51.87 |
GoodRx Holdings (GDRX) | United States | $3.006B | 152.20 |
Life Times (LTH) | United States | $2.911B | 30.50 |
Premier (PINC) | United States | $2.350B | 8.79 |
AMN Healthcare Services Inc (AMN) | United States | $2.284B | 7.39 |
Agilon Health (AGL) | United States | $2.134B | 0.00 |
Teladoc Health (TDOC) | United States | $2.069B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.948B | 0.00 |
NovoCure (NVCR) | Jersey | $1.725B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.407B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $1.296B | 0.00 |
Pediatrix Medical (MD) | United States | $0.715B | 7.59 |
QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
Embecta (EMBC) | United States | $0.591B | 3.90 |
InnovAge Holding (INNV) | United States | $0.579B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.548B | 0.00 |
CareDx (CDNA) | United States | $0.527B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.527B | 0.00 |
LifeMD (LFMD) | United States | $0.504B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.503B | 0.00 |
Enhabit (EHAB) | United States | $0.487B | 48.50 |
Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
Beauty Health (SKIN) | United States | $0.423B | 0.00 |
MultiPlan (MPLN) | United States | $0.391B | 0.00 |
ModivCare (MODV) | United States | $0.373B | 6.99 |
DocGo (DCGO) | United States | $0.365B | 19.44 |
Sera Prognostics (SERA) | United States | $0.302B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.264B | 0.00 |
Sharecare (SHCR) | United States | $0.250B | 0.00 |
Biodesix (BDSX) | United States | $0.178B | 0.00 |
So-Young (SY) | China | $0.137B | 46.00 |
Oncology Institute (TOI) | United States | $0.068B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
NeueHealth (NEUE) | United States | $0.053B | 7.13 |
Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
Nutex Health (NUTX) | United States | $0.032B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
OncoCyte (OCX) | United States | $0.023B | 0.00 |
DermTech (DMTK) | United States | $0.022B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.015B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.006B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |